SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study - Aix-Marseille Université Access content directly
Conference Papers Year : 2017

SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study

F. Maurice
  • Function : Author
P. Ancel
  • Function : Author
E. Mayoux
  • Function : Author
I. Abdesselam
  • Function : Author
P. Darmon
  • Function : Author
M. Grino
  • Function : Author
A. Dutour
  • Function : Author
No file

Dates and versions

hal-01784725 , version 1 (03-05-2018)

Identifiers

  • HAL Id : hal-01784725 , version 1

Cite

F. Maurice, P. Ancel, E. Mayoux, I. Abdesselam, F. Kober, et al.. SGLT2 inhibition by empagliflozin attenuates ectopic fat accumulation and improves cardiac index in parallel to ketone bodies production: the EMPAFAT study. 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD), EASD, Sep 2017, Lisbon, Portugal. pp.S414--S414. ⟨hal-01784725⟩
22 View
0 Download

Share

Gmail Facebook X LinkedIn More